Type I Interferon Receptor Deficiency Prevents Murine Sjogren's Syndrome
Type I Interferon Receptor Deficiency Prevents Murine Sjogren's Syndrome
复制标题
DOI:
10.1177/0022034513483315
复制
发表时间:
2013-05-01
影响因子:
7.6
通讯作者:
Deshmukh, U. S.
中科院分区:
文献类型:
--
作者:
Szczerba, B. M.;Rybakowska, P. D.;Deshmukh, U. S.
In Sjogren's Syndrome (SS), inherent glandular defects, autoimmunity, and mononuclear cell infiltration within the salivary glands cause reduced salivation leading to xerostomia. Excessive production of type I interferons (IFN), triggered by environmental and genetic factors, is considered pathogenic in this disorder. However, whether type I IFN production is causative or an outcome of the disease process is not known. To address this question, we introduced a deficiency of interferon alpha receptor 1 (Ifnar1) into B6.Aec1Aec2 mice, which are known to have the genetic loci necessary for developing a SS-like disorder. This new mouse strain, B6.Aec1Aec2Ifnar1(-/-), lacking type I IFN-mediated signaling, was characterized for pilocarpine-induced salivation, the presence of serum autoantibodies, sialoadenitis, and dacryoadenitis. Compared with the B6.Aec1Aec2Ifnar1(+/+) (wild-type) mice, the B6.Aec1Aec2Ifnar1(-/-)(knockout) mice had significantly lower mononuclear cell infiltration in the salivary and lacrimal glands. The knockout mice were completely protected from salivary gland dysfunction. Surprisingly, they had a robust autoantibody response comparable with that of the wild-type mice. These findings demonstrate that, in the absence of type I IFN-mediated signaling, systemic autoantibody responses can be dissociated from glandular pathology. Our study suggests that, in genetically susceptible individuals, the type I IFN pathway can instigate certain features of SS.